Skip to main content
Log In
Create Account
Home
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Watchlist
Collapse
Light
Dark
European Medical Solutions (EBR:ALEMS)
Belgium
· Delayed Price · Currency is EUR
Watchlist
Compare
4.903
+0.052 (1.07%)
May 2, 2025, 4:20 PM CET
Overview
Financials
Statistics
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
Metrics
NEW
Annual
Revenue by Product
Fiscal year is January - December.
Download
Year Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '16
Dec 31, 2016
Dec '15
Dec 31, 2015
Dec '14
Dec 31, 2014
Immunotherapy Treatments for Environmental and Food Allergies
40.56M
Log In
Log In
Log In
Log In
Immunotherapy Treatments for Environmental and Food Allergies Growth
15.01%
Log In
Log In
Log In
Log In
Revenue by Geography
Fiscal year is January - December.
Download
Year Ending
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '16
Dec 31, 2016
Dec '15
Dec 31, 2015
Dec '14
Dec 31, 2014
Europe
24.88M
Log In
Log In
Log In
Log In
Europe Growth
4.19%
Log In
Log In
Log In
Log In
North and South America
7.45M
Log In
Log In
Log In
Log In
North and South America Growth
98.91%
Log In
Log In
Log In
Log In
Asia
2.86M
Log In
Log In
Log In
Log In
Asia Growth
-31.64%
Log In
Log In
Log In
Log In
Middle East
1.84M
Log In
Log In
Log In
Log In
Middle East Growth
92.55%
Log In
Log In
Log In
Log In
Africa
1.59M
Log In
Log In
Log In
Log In
Africa Growth
27.54%
Log In
Log In
Log In
Log In
Commonwealth of Independent States
1.49M
Log In
Log In
Log In
Log In
Commonwealth of Independent States Growth
65.92%
Log In
Log In
Log In
Log In
Oceania
456.00K
Log In
Log In
Log In
Log In
Oceania Growth
26.32%
Log In
Log In
Log In
Log In
Global
-
Log In
Log In
Log In
Log In
Global Growth
-
Log In
Log In
Log In
Log In